Boule Diagnostics signs agreement with CVS Group

Boule Diagnostics has signed an agreement with CVS Group, one of UK’s largest companies in veterinary medicine and diagnostics. The agreement spans over 7 years and includes delivery of instruments and consumables to an estimated value of at least SEK 25 m.

“CVS Group owns a number of veterinary diagnostic labs as well as close to 250 veterinary clinics in the UK. The agreement represents a major success for our blood analysis systems on the veterinary market and it is gratifying that CVS has chosen to cooperate with us for their entire operations in the UK. Given their strong market position and know-how in the veterinary industry, this is of great importance for our continued commercial development”, comments Ernst Westman, CEO and president of Boule Diagnostics.

“We are the UK’s largest veterinary corporate and we continue to grow. Our success is based on the high standards we set for ourselves – and our partners. Boule has proven to deliver quality and they live up to the high standards we set for manufacturers, which was decisive in choosing them as a supplier”, comments Martyn Carpenter, Director of Laboratories, CVS Group.

For more information, please contact: 
Ernst Westman, CEO and president, Boule Diagnostics AB, phone: +46 708-60 88 63

The information in this press release is such that Boule Diagnostics AB must disclose it in accordance with the Securities Market Act and/or the Financial Instruments Trading. The information was submitted for publication at 8 am (CET), August 27, 2013.


About Boule Diagnostics AB
Boule Diagnostics AB is a fast-growing diagnostics company, developing and manufacturing systems and consumables for hematology diagnostics for the public healthcare providers worldwide. The company is primarily focused on small and medium-sized hospitals, clinics and laboratories in outpatient care as well as other diagnostics companies in both human and veterinary hematology. The group is comprised of operating subsidiaries in Sweden, the US and China. Boule Diagnostics’ share is, since 2011, traded on NASDAQ OMX Nordic.

About CVS Group
CVS Group plc is one of the leading veterinary services providers in the UK. In total the Group now operates 248 surgeries, and 4 diagnostic laboratories across the UK and remains the largest operator in the market, through its wholly owned subsidiary, CVS(UK)Limited.


  • Subscribe to our news